TCTMD (8/11, McKeown) reports researchers conducted a review study and found “despite evidence that prescription stimulants used to treat attention-deficit/hyperactivity disorder (ADHD) raise blood pressure and resting heart rate, the literature is unclear with regard to the long-term CV risks of using them.” The researchers also found that “prescribing rates of the medications have been climbing in the United States while global rates of ADHD remain relatively stable.” The review study was published in JACC.
Related Links:
— “ADHD Drug Overprescribing Raises Concerns Over Future CV Events, “L.A. McKeown, TCTMD, August 11, 2020